https://www.selleckchem.com/pr....oducts/Adriamycin.ht
Furthermore, T cells expressing chPD1 receptors reduced an established tumor burden and led to long-term tumor free survival in all types of solid tumors tested. ChPD1 T cells did not survive longer than 14 days in vivo, however treatment with chPD1 T cells induced protective host anti-tumor memory responses in tumor-bearing mice. Therefore, adoptive transfer of chPD1 T cells could be a novel therapeutic strategy to treat multiple types of solid cancer. This article is protected by copyright. All rights reserved.Cryopreservation of i
Like
Comment
Share
